![pabear5 Profile](https://abs.twimg.com/sticky/default_profile_images/default_profile_x96.png)
pabear5
@pabear5
Followers
35
Following
2K
Statuses
747
Joined March 2016
@Brandon_Beaber @DocforMS @OMRF @AaronBosterMD @drbarrysinger @MSViewsandNews @WHO That’s exactly my point! So what's the reason for choosing a drug which is much more expensive?
0
0
0
@Brandon_Beaber @ThesisMeHQ Apart from the cost, do you think there are differences in effectiveness and side effects between ocrelizumab and rituximab?
0
0
1
@Dr_Agibus @DrePetronille Merci beaucoup pour votre travail que @docdu16 a bien défini « herculéen ». Je vous signale seulement: 1/2 vie plus longues au lieu de 1/2 plus longues, à propos des triptans. Merci encore 🤗
1
0
2
@MicieliA_MD Further confirmation that discharge home a mild stroke patient without first having done a carotid doppler or CTA is too risky.
0
0
1
RT @MarcoRizzoDSP: I governi delle regioni amministrate dalla destra tagliano la sanità pubblica ma sentire gli esponenti della cosiddetta…
0
413
0
@LorenzoPinelli @LyellJ @MichaelLimMD @ContinuumAAN How to distinguish between conflict and contact? I guess it's not easy.
1
0
0
@ProfRobHoward DOMINO trial: “Many of the investigators have received support from pharmaceutical companies,for example, to attend conferences, for giving lectures,for the provision of consultancy, for the conduct of research or for the development of research infrastructure….” @pash22
0
0
0